Hims & Hers vs. LifeMD: prices, fine print, and the honest verdict

Tirzepatide pricing

Hims & Hers offers tirzepatide without a published price we could capture. LifeMD: $597 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, including the mandatory $149/mo membership.

Semaglutide pricing

Only LifeMD publishes a semaglutide price here: Semaglutide runs $348 a month all-in. Hims & Hers offers semaglutide without a published price.

Different products, not just different prices

Hims & Hers fulfills the FDA-approved product — reviewed manufacturing, verified identity and sterility, stable legal status — while LifeMD sells compounded medication: pharmacy-prepared, not FDA-reviewed, and operating under the narrower post-shortage pathways our legal guide tracks. The compounded discount is partly a risk premium; whether it's worth taking depends on the pharmacy behind it and your tolerance for regulatory turbulence.

Transparency

Hims & Hers: No price published (verified 2026-08-05); names its pharmacy — brand fulfillment; compounded program closed to new patients. LifeMD: Third-party-reported (verified 2026-08-05); dispensing pharmacy not publicly named. In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.

Commitment & cancellation

Hims & Hers: plan recurs; plan recurs until cancelled. LifeMD: program fee recurs monthly; program fee recurs until cancelled; $149/mo membership recurs until cancelled.

Two ladders, side by side

Titration is where these pricing structures stop being abstractions: LifeMD holds $597 on every rung (four-month titration: exactly $2,388). A flat ladder makes dose decisions purely clinical; a scaled one attaches an invoice to every escalation — including the post-plateau bump from 10 to 12.5 mg that many patients eventually face. Full framework: the titration cost guide.

The semaglutide board

Only LifeMD fields a verified semaglutide price here — $348/month all-in (#19 of 19) — while Hims & Hers routes semaglutide demand to brand Wegovy at $349 flat. For a buyer starting on the cheaper molecule with a likely upgrade later, single-molecule programs mean a future re-shop; dual-molecule ones price the whole arc.

The five normalizations, applied to this pair

1 · All-in, not advertised. Hims & Hers bills at manufacturer/insurance rates plus any stated program fee; LifeMD's ranked figure is $597 ($448 medication + $149 mandatory membership). 2 · Maintenance basis. LifeMD is dose-flat, so its entry and 10 mg figures coincide. 3 · Terms separated. LifeMD: standing $597, no prepaid tier — standing rates rank, prepaid effectives are labeled beside them. 4 · Evidence tiered. Hims & Hers: no price published, read 2026-08-05; LifeMD: third-party-reported, read 2026-08-05. 5 · Pharmacy weighed. Hims & Hers names brand fulfillment; compounded program closed to new patients; LifeMD names no pharmacy — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.

Fine print, itemized

Hims & Hers: no membership — the medication figure is the billed figure; plan recurs until cancelled. LifeMD: a mandatory $149/mo membership folded into our all-in figure; program fee recurs until cancelled; commitment: program fee recurs monthly. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.

Transparency, audited

Hims & Hers carries no price published pricing (last read 2026-08-05); pharmacy disclosure is its strong suit — brand fulfillment; compounded program closed to new patients, brand fulfillment. LifeMD carries third-party-reported pricing (last read 2026-08-05); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.

Switching between them

The switch mechanics are symmetric: new intake, new script, new pharmacy, old plan cancelled in writing. Budget a shipping-gap week, confirm the destination program's price at your current dose (not its starter figure), and if the move is also a molecule change, loop the prescriber in per the switching guide.

Refills, shipping, and the week-to-week reality

Logistics decide more churn than price does, so put them on the record: Hims & Hers: shipping included; consultation included in plan; async visit model. LifeMD: shipping included; consultation video visits included in program fee; video visit model. Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.

Who should pick which

Pick Hims & Hers if a named pharmacy is non-negotiable for you; only the FDA-approved product will do; you refuse membership fees on principle. Pick LifeMD if you want a price that survives titration; you want the insurance paperwork done for you. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.

What verification would take

For Hims & Hers, ranking would require: any published price at all, on a page we can capture and date; the dose structure (flat or scaled, with the 10 mg tier stated); the pharmacy's name, 503A/503B status, and state licensure; commitment and cancellation terms verbatim. We publish the checklist because the gap is fixable — providers that clear it get ranked on the same arithmetic as everyone else, and readers who ask these questions get the answers this page can't yet print.

If neither one fits

Widen the frame one step and the strongest adjacent options are Eden at $408 (dose-scaled, $99 membership included); MEDVi at $399 (flat, no membership); Remedy Meds at $399 (flat, no membership) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.

The verdict

This one is a product decision more than a price decision — cheapest-possible compounded versus FDA-approved brand. Both records, with dates and sources, live in the pricing database.